Corbion Purac increase polylactic acid capacity 75 kilo tonne per annum

Corbion to increase polylactic acid capacity

11:34 AM, 3rd November 2014
Corbion Purac  increase polylactic acid capacity 75 kilo tonne per annum

GORINCHEM, NETHERLANDS: Corbion Purac will accelerate its thrust into the biotechnology arena, making the next step in the bioplastics value chain by becoming a polylactic acid producer. With entry into polylactic acid, Corbion Purac intends to bring new biodegradable solutions to the plastics industry, and increase global polylactic acid production capacity by a further 75 kilo tonne per annum. This announcement forms a part of Corbion’s updated strategic direction for 2015 - 2018.

Corbion Purac will continue selling lactides to both existing and new polylactic acid polymerization customers. Lactide sales for the coatings and adhesives markets will also continue. Many of Corbion’s existing polymerization customers have already successfully built a strong local presence and distribution channel, with great market coverage. Worldwide polylactic acid capacity is almost sold out and with the polylactic acid market expected to grow to 600 kilo tonne per annum by 2025, the market is seeking additional polylactic acid suppliers. Corbion intends to invest in a 75 kilo tonne per annum polylactic acid plant in Thailand.

“As part of our strategic review we confirmed there is an attractive demand outlook for polylactic acid, albeit at a lower growth pace than previously assumed. Given our strong position in lactic acid, our unique high heat technology and the market need for a second polylactic acid producer, we plan to forward integrate in the bioplastics value chain, from being a lactide provider to a polylactic acid producer,” said Tjerk de Ruiter, CEO, Corbion.

 

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


New membrane with adjustable pore size

ENSCHEDE, THE NETHERLANDS: A new membrane, developed by University of Twente scientists, can be made more or less porous ‘on demand.’ In t ...

Read more
PPG gets Mexican regulatory approval for acquisition of Comex

PITTSBURGH, US: PPG Industries has received a favorable ruling from Mexico’s Federal Economic Competition Commission on its previously announced ...

Read more
Bayer completes acquisition of Dihon Pharmaceutical

LEVERKUSEN, GERMANY: Bayer has completed the acquisition of 100 per cent of the shares of Dihon Pharmaceutical Group Co Ltd Kunming, Yunnan, China, a ...

Read more
Cirrus Pharmaceuticals to invest in cGMP suite in North Carolina, US

MORRISVILLE, US: Cirrus Pharmaceuticals, a Kemwell com,pany which is a 100 per cent services oriented company providing pharmaceutical contract develo ...

Read more
Vencorex plans aliphatic isocyanates capacity expansion

SAINT-DENIS, FRANCE: Vencorex is expanding its capacity of aliphatic isocyanates to further strengthen the company’s positions world-wide. Sever ...

Read more
Lonza, Bristol-Myers Squibb expand biologics manufacturing agreement

NEW YORK, US/BASEL, SWITZERLAND: Lonza and Bristol-Myers Squibb Company announced a multi-year expansion of their existing biologics manufacturing agr ...

Read more